Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Focal Segmental Glomerulosclerosis Clinical Trial
Brief Summary: The FSGS Clinical Trial is a multi-center, prospective, controlled, open label randomized trial designed to determine if treatment with mycophenolate mofetil (MMF) in conjunction with pulse steroids is superior to treatment with Cyclosporine-A (CSA) in inducing remission from proteinuria over 12 months.